• Acsensia Diabetes Care
• Agfa
• Allergan
• Arthrex

Preview of job titles: 

• Analyst, Project Management 
• Assoc. Dir. Packaging Technology
• CEO
• Deputy Director Medical Device Vigilance, Global Pharmacovigilance
  

In this report they will discuss:

• What the successful realisation of these incoming global UDI regulations mean for healthcare
• The benefits hospitals and clinics can get from UDI's
• The practical challenges during UDI implementation 

With Europe facing rapidly-approaching new UDI regulations, plans need to be put in place now in order to meet the deadlines, but the requirements from authorities are not yet clear, therefore manufacturers are unable to commit to costly projects. The question on medical device manufacturers’ minds is – what can we safely be doing right now, to best set ourselves up for the upcoming regulations?

In light of this, Pharma IQ moderated a roundtable conversation between three UDI experts, Tommy Røsholt, Contracting Project Manager for UDI compliance at Oticon, Tom Jones, UDI Program Director for Johnson & Johnson Supply Chain, and Jenny Young, Contact Project Manager MDR at Convatec.

Organisations of all sizes are recognising the critical role of data quality in information governance and stewardship driven by broader enterprise information management initiatives.

Pharma IQ surveyed leading industry professionals on their challenges and investment plans for building a master data management (MDM) strategy to enable global compliance. The results have been presented in the following infographic to ensure your data is consistent, secure and compliant.

Download the infographic now >>

Other key benefits of downloading the infographic:

• Analyse the industry’s main challenges and key solutions for developing a master data strategy
• Understand best practices for obtaining guidance on global regulatory requirements  
• Exploring the greatest area of opportunity for improvement across the healthcare ecosystem

Complying with international requirements and standards to ensure global UDI compliance is a key challenge for medical device manufacturers. Contending with changing deadlines and often ambiguous guidelines, manufacturers are looking for clarity from regulators on what exactly is required of them.

In light of this and the delay to EUDAMED, Pharma IQ have created a post-show report highlighting the most exciting takeaways from the 2019 Global UDI and Master Data Forum.

Download the full report now >>

Other key benefits of downloading the report:

• Explore the greatest area of opportunity for improvement across the healthcare ecosystem
• A summary of the key challenges in 2020 and the changes that need to be implemented across the industry in order to meet these challenges
• Key takeaways from the 2019 event
• What does the future hold for Global UDI’s and Master Data Strategy – an overview of the 2020 event
  

While UDI (Unique Device Identification) regulations support patient care objectives, many hospitals don’t yet know how to implement this requirement, which can hinder the progression to track information of a specific product.

With a view to ensure hospitals are continuing to make headway to overcome these implementation roadblocks, Pharma IQ has created a guidebook of the collated lessons learned by hospitals during the implementation of UDIs for medical devices. The guidebook also analyses how the conduct of manufacturers and hospitals can be altered to optimise the rollout of a project and avoid incurring any detriment.

Download the guidebook now >>

Other key benefits of downloading the guidebook:

• Understand the benefits of UDIs for medical devices while meeting the regulatory expectation
• Explore the implementation roadblocks that hinder hospitals today
• Analyse how to enhance the success of the practical implementation of UDIs for medical devices and evade any threats to patient safety or waste in resources
  

The European Commission recently announced a two-year delay for the launch of the new version of European Database on Medical Devices (EUDAMED) being built to support the European Medical Device Regulation (MDR) including the module that will hold unique device identifiers (UDIs) and other required data on medical devices.

In a healthcare purchasing news article, Karen Conway, Vice President, Healthcare Value, GHX, responds to the state of regulatory unreadiness by offering standard practice solutions to prepare for EUDAMED, and improve transparency and coordination of information regarding medical device availability in the EU market.

Download the full article now >> 

Ahead of this years European UDI forum, Dawn Fowler, Director of UDI and Master Data Management, Masimo and Pharma IQ wrote a report on data management and UDI’s.

In this report they will discuss:

• The transition from GUDID to EUDAMED for FDA-compliant manufacturers
• Building a robust UDI MDM infrastructure
• What are the next steps for this industry

As the date of application of the EU MDR remains May 26, 2020, the European Commission officially stated that EUDAMED’s launch will be delayed to the date of application for in-vitro medical devices in May 2022.

Therefore is there any need to care about UDI for now anymore?

In the following article, Patrick Pfau, co-founder of p36 explains why UDI will still be necessary considering the requirements of EU MDR and how to overcome upcoming challenges related to UDI.